Whether Estramustine has been launched in China and the market supply situation

Estramustine (Estramustine) is an oral anti-androgen drug, mainly used for adjuvant treatment of prostate cancer and maintenance treatment of metastatic prostate cancer. Its mechanism of action combines the characteristics of estrogen and nitrogen mustard, which can not only inhibit the proliferation of tumor cells, but also interfere with DNA synthesis, thus exerting anti-cancer effects. Clinically, estramustine is often used as part of combination chemotherapy or endocrine therapy, especially for patients with androgen-sensitive prostate cancer.

in the country, estramustine has been officially launched and included in the medical insurance catalog. According to the latest market information, the domestic price of capsules with the domestic specification of 0.14g*40 capsules is approximately 3,000 yuan. Due to the inclusion in medical insurance, eligible patients can enjoy a certain percentage of reimbursement when purchasing drugs in hospital pharmacies, thus reducing the financial burden and improving drug accessibility.

In overseas markets, the brand name of estramustine is Emcyt, and the common specifications are 140mg*30 capsules. The average retail price is about 514.27 US dollars, after discounts, it is about 634.99USD. Compared with domestic prices, overseas drug prices are significantly higher, and they usually need to be purchased through hospital prescriptions. Reimbursement policies in different countries and regions vary greatly, resulting in significant differences in patient access costs and convenience.

Overall, the supply of estramustine in the domestic market is relatively stable, and medical insurance coverage allows patients to obtain treatment at a lower cost. Although the prices in overseas markets are higher, they are also strict in drug management and quality supervision. For prostate cancer patients who require long-term maintenance treatment, the accessibility and economic advantages of estramustine in China are obvious. At the same time, patients still need to strictly follow medical instructions when using it, and regularly monitor blood indicators and liver function to ensure the safety of medication and stable efficacy.

Reference materials:https://www.drugs.com/